Back

Mechanistic insights into the interactions between cancer drivers and the tumour immune microenvironment

Misetic, H.; Keddar, M. R.; Jeannon, J.-P.; Ciccarelli, F. D.

2023-01-24 cancer biology
10.1101/2023.01.24.525325 bioRxiv
Show abstract

The crosstalk between cancer and the tumour immune microenvironment (TIME) has attracted significant interest because of its impact on cancer evolution and response to treatment. Despite this, cancer-specific tumour-TIME interactions and their mechanisms of action are still poorly understood. Here we identified the interactions between cancer-specific genetic drivers and anti- or pro-tumour TIME features in individual samples of 32 cancer types. The resulting 477 TIME drivers are multifunctional genes whose alterations are selected early in cancer evolution and recur across and within cancer types. Moreover, the anti-tumour TIME driver burden is predictive of overall response to immunotherapy. Focusing on head and neck squamous cancer (HNSC), we rebuilt the functional networks linking specific TIME driver alterations to the TIME state. We showed that TIME driver alterations predict the immune profiles of HNSC molecular subtypes, and that deregulation of keratinization, apoptosis and interferon signalling underpin specific driver-TIME interactions. Overall, our study provides a comprehensive resource of TIME drivers giving mechanistic insights into their immune-regulatory role.

Matching journals

The top 10 journals account for 50% of the predicted probability mass.

1
Nature Communications
4913 papers in training set
Top 14%
12.4%
2
Cell Reports
1338 papers in training set
Top 3%
10.0%
3
Cancer Cell
38 papers in training set
Top 0.3%
4.8%
4
Genome Medicine
154 papers in training set
Top 2%
3.6%
5
Cancer Research
116 papers in training set
Top 0.9%
3.6%
6
Oncogene
76 papers in training set
Top 0.5%
3.6%
7
Cancers
200 papers in training set
Top 2%
3.6%
8
Journal of Experimental & Clinical Cancer Research
25 papers in training set
Top 0.1%
3.6%
9
eLife
5422 papers in training set
Top 31%
2.7%
10
Frontiers in Immunology
586 papers in training set
Top 3%
2.3%
50% of probability mass above
11
Molecular Oncology
50 papers in training set
Top 0.3%
2.1%
12
Cell Genomics
162 papers in training set
Top 3%
1.9%
13
iScience
1063 papers in training set
Top 12%
1.9%
14
Journal for ImmunoTherapy of Cancer
64 papers in training set
Top 0.6%
1.8%
15
PLOS Computational Biology
1633 papers in training set
Top 15%
1.8%
16
Cell Reports Medicine
140 papers in training set
Top 4%
1.7%
17
EMBO Molecular Medicine
85 papers in training set
Top 2%
1.7%
18
PLOS ONE
4510 papers in training set
Top 54%
1.7%
19
Cancer Immunology Research
34 papers in training set
Top 0.3%
1.6%
20
Developmental Cell
168 papers in training set
Top 9%
1.5%
21
Nucleic Acids Research
1128 papers in training set
Top 13%
1.3%
22
Communications Biology
886 papers in training set
Top 13%
1.3%
23
Cell Communication and Signaling
35 papers in training set
Top 0.7%
1.2%
24
The EMBO Journal
267 papers in training set
Top 3%
1.1%
25
Science Advances
1098 papers in training set
Top 25%
0.9%
26
Scientific Reports
3102 papers in training set
Top 69%
0.9%
27
Advanced Science
249 papers in training set
Top 17%
0.9%
28
EMBO reports
136 papers in training set
Top 6%
0.8%
29
Immunity
58 papers in training set
Top 4%
0.7%
30
Cell Death & Disease
126 papers in training set
Top 3%
0.7%